These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25972509)

  • 1. Incipient renal transplant dysfunction associates with tubular syndecan-1 expression and shedding.
    Adepu S; Rosman CW; Dam W; van Dijk MC; Navis G; van Goor H; Bakker SJ; van den Born J
    Am J Physiol Renal Physiol; 2015 Jul; 309(2):F137-45. PubMed ID: 25972509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubular epithelial syndecan-1 maintains renal function in murine ischemia/reperfusion and human transplantation.
    Celie JW; Katta KK; Adepu S; Melenhorst WB; Reijmers RM; Slot EM; Beelen RH; Spaargaren M; Ploeg RJ; Navis G; van der Heide JJ; van Dijk MC; van Goor H; van den Born J
    Kidney Int; 2012 Apr; 81(7):651-61. PubMed ID: 22237752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Damage of the endothelial glycocalyx in chronic kidney disease.
    Padberg JS; Wiesinger A; di Marco GS; Reuter S; Grabner A; Kentrup D; Lukasz A; Oberleithner H; Pavenstädt H; Brand M; Kümpers P
    Atherosclerosis; 2014 Jun; 234(2):335-43. PubMed ID: 24727235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM17 up-regulation in renal transplant dysfunction and non-transplant-related renal fibrosis.
    Mulder GM; Melenhorst WB; Celie JW; Kloosterhuis NJ; Hillebrands JL; Ploeg RJ; Seelen MA; Visser L; van Dijk MC; van Goor H
    Nephrol Dial Transplant; 2012 May; 27(5):2114-22. PubMed ID: 22015440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial Glycocalyx Damage and Renal Dysfunction in HIV Patients Receiving Combined Antiretroviral Therapy.
    Meneses GC; Cavalcante MG; da Silva Junior GB; Martins AMC; Neto RDJP; Libório AB; De Francesco Daher E
    AIDS Res Hum Retroviruses; 2017 Jul; 33(7):703-710. PubMed ID: 28260391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma syndecan-1 in hemodialysis patients associates with survival and lower markers of volume status.
    Koch J; Idzerda NMA; Dam W; Assa S; Franssen CFM; van den Born J
    Am J Physiol Renal Physiol; 2019 Jan; 316(1):F121-F127. PubMed ID: 30379102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADAM17 upregulation in human renal disease: a role in modulating TGF-alpha availability?
    Melenhorst WB; Visser L; Timmer A; van den Heuvel MC; Stegeman CA; van Goor H
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F781-90. PubMed ID: 19535569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of kidney function with changes in the endothelial surface layer.
    Dane MJ; Khairoun M; Lee DH; van den Berg BM; Eskens BJ; Boels MG; van Teeffelen JW; Rops AL; van der Vlag J; van Zonneveld AJ; Reinders ME; Vink H; Rabelink TJ
    Clin J Am Soc Nephrol; 2014 Apr; 9(4):698-704. PubMed ID: 24458084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic syndecan-1 changes associate with dyslipidemia after renal transplantation.
    Adepu S; Katta K; Tietge UJ; Kwakernaak AJ; Dam W; van Goor H; Dullaart RP; Navis GJ; Bakker SJ; van den Born J
    Am J Transplant; 2014 Oct; 14(10):2328-38. PubMed ID: 25154787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low versus standard pressure pneumoperitoneum on renal syndecan-1 shedding and VEGF receptor-2 expression in living-donor nephrectomy: a randomized controlled study.
    Aditianingsih D; Mochtar CA; Lydia A; Siregar NC; Margyaningsih NI; Madjid AS; Suwarto S
    BMC Anesthesiol; 2020 Feb; 20(1):37. PubMed ID: 32019488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal N(epsilon)-carboxymethyllysine deposition after kidney transplantation.
    Baumann M; Caron M; Schmaderer C; Schulte C; Viklicky O; von Weyhern CW; Lutz J; Heemann U
    Transplantation; 2008 Jul; 86(2):330-5. PubMed ID: 18645498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An acute rise of plasma Na
    Koch J; Idzerda NMA; Ettema EM; Kuipers J; Dam W; van den Born J; Franssen CFM
    Am J Physiol Renal Physiol; 2020 Aug; 319(2):F171-F177. PubMed ID: 32538148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of cell proliferation by clusterin in the renal tissue repair phase after ischemia-reperfusion injury.
    Nguan CY; Guan Q; Gleave ME; Du C
    Am J Physiol Renal Physiol; 2014 Apr; 306(7):F724-33. PubMed ID: 24477687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADAM19 expression in human nephrogenesis and renal disease: associations with clinical and structural deterioration.
    Melenhorst WB; van den Heuvel MC; Timmer A; Huitema S; Bulthuis M; Timens W; van Goor H
    Kidney Int; 2006 Oct; 70(7):1269-78. PubMed ID: 16900093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shedding of syndecan-4 promotes immune cell recruitment and mitigates cardiac dysfunction after lipopolysaccharide challenge in mice.
    Strand ME; Aronsen JM; Braathen B; Sjaastad I; Kvaløy H; Tønnessen T; Christensen G; Lunde IG
    J Mol Cell Cardiol; 2015 Nov; 88():133-44. PubMed ID: 26449522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A transmembrane C-terminal fragment of syndecan-1 is generated by the metalloproteinase ADAM17 and promotes lung epithelial tumor cell migration and lung metastasis formation.
    Pasqualon T; Pruessmeyer J; Weidenfeld S; Babendreyer A; Groth E; Schumacher J; Schwarz N; Denecke B; Jahr H; Zimmermann P; Dreymueller D; Ludwig A
    Cell Mol Life Sci; 2015 Oct; 72(19):3783-801. PubMed ID: 25912030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers of endothelial injury in plasma are dependent on kidney function.
    Hahn RG; Hasselgren E; Björne H; Zdolsek M; Zdolsek J
    Clin Hemorheol Microcirc; 2019; 72(2):161-168. PubMed ID: 30714949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial glycocalyx damage in kidney disease correlates with uraemic toxins and endothelial dysfunction.
    Liew H; Roberts MA; Pope A; McMahon LP
    BMC Nephrol; 2021 Jan; 22(1):21. PubMed ID: 33423673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma concentrations of syndecan-1 are dependent on kidney function.
    Hahn RG; Zdolsek M; Zdolsek J
    Acta Anaesthesiol Scand; 2021 Jul; 65(6):809-815. PubMed ID: 33595099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-1 in Acute Decompensated Heart Failure--Association With Renal Function and Mortality.
    Neves FM; Meneses GC; Sousa NE; Menezes RR; Parahyba MC; Martins AM; Libório AB
    Circ J; 2015; 79(7):1511-9. PubMed ID: 25891890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.